SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-046165
Filing Date
2015-08-04
Accepted
2015-08-04 16:31:02
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v415947_10q.htm 10-Q 465630
2 EXHIBIT 31.1 v415947_ex31-1.htm EX-31.1 11838
3 EXHIBIT 31.2 v415947_ex31-2.htm EX-31.2 11806
4 EXHIBIT 32.1 v415947_ex32-1.htm EX-32.1 6699
  Complete submission text file 0001144204-15-046165.txt   3879648

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20150630.xml EX-101.INS 843306
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20150630.xsd EX-101.SCH 35486
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20150630_cal.xml EX-101.CAL 43128
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20150630_def.xml EX-101.DEF 241874
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20150630_lab.xml EX-101.LAB 276295
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20150630_pre.xml EX-101.PRE 278473
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 151025964
SIC: 2834 Pharmaceutical Preparations